Joseph Grossman
CEO
Joseph Grossman
CEO
Joseph received his M.D. degree from the Universidad del Noreste Escuela de Medicina, in Tampico, Mexico, in 1987. Previously he had received his Master of Social Work and A.B. in Biological Sciences from Rutgers University, in New Brunswick, NJ.
Joseph recently was issued a patent for a method that will permit the opioid tapers that are recommended by most governmental agencies to be formulated and evaluated in randomized controlled trials (RCT), something not previously attempted.
He is working on materials and presentations designed to demonstrate the value of the invention and to facilitate the RCTs that will demonstrate the efficacy of the opioid tapering guidelines promulgated by these U.S. health and veterans agencies.
Joseph previously edited medical journal articles for Convergence CT and provided direct writing assistance to physician authors.
Previous work includes providing psychiatric social work services to nursing home patients. He has extensive experience providing psychiatric services with youth placed in residential treatment, some with serious substance abuse issues. He provided social work administration at Hawthorne Cedar Knolls School and Treatment Center and was Director of Adolescent Psychiatric Social Work at Metropolitan Hospital in New York City.
Joseph recently was issued a patent for a method that will permit the opioid tapers that are recommended by most governmental agencies to be formulated and evaluated in randomized controlled trials (RCT), something not previously attempted.
He is working on materials and presentations designed to demonstrate the value of the invention and to facilitate the RCTs that will demonstrate the efficacy of the opioid tapering guidelines promulgated by these U.S. health and veterans agencies.
Joseph previously edited medical journal articles for Convergence CT and provided direct writing assistance to physician authors.
Previous work includes providing psychiatric social work services to nursing home patients. He has extensive experience providing psychiatric services with youth placed in residential treatment, some with serious substance abuse issues. He provided social work administration at Hawthorne Cedar Knolls School and Treatment Center and was Director of Adolescent Psychiatric Social Work at Metropolitan Hospital in New York City.
- Phone:+1 (831) 247-7294
- Email:info@pssusa.net
Jim Behrman
Consultant
Jim Behrman
Consultant
Jim received his B.A. and Master of Social Work from Rutgers University in New Brunswick, NJ. He trained at the Ackerman Institute for the Family and at the Center for Modern Psychoanalytic Studies, both in New York City. He was Director of Social Services at Sarasota Palms Hospital. Jim has 28 years of clinical experience, including treating children, families and individuals with substance use disorders.
Steve Deutsch
Consultant
Steve Deutsch
Consultant
Steven got his B.A. from Brooklyn College and a Master's in Special Education with a specialty in teaching the visually impaired and blind. He worked for 34 years in the field, much of it with middle school students in New York City public schools. He was a chaplain’s assistant in Vietnam and is called on to perform weddings and deliver eulogies. Steven currently is involved with providing therapy dogs to patients in a variety of in-patient settings and also does work rescuing our canine friends from shelters. He does volunteer liaison work with the public in Balboa Park in San Diego.
Vincent Idemyor
Consultant
Vincent Idemyor
Consultant
Dr. Vincent Idemyor is a clinical pharmacologist who received his bachelor’s and his Doctor of Pharmacy degree from the University of Minnesota College of Pharmacy.
In 1991, Dr. Idemyor joined the teaching faculty at the University of Illinois College of Medicine, at Chicago, and was Mercy Hospital Medical Center, Head, Section of Clinical Pharmacology 1991-1999. While at Mercy Hospital, he did some of the early clinical research work in the area of antibiotic resistance to bacterial infections in hospitals. Idemyor was the Director, Department of Pharmaceutical Services, at Advocate Bethany Hospital in Chicago from 2000 to 2006. In 2006, he led the United Nations accountability project in Nigeria, reviewing how the Global Fund for HIV, TB and malaria funds had been used at numerous agencies throughout the country.
In 2009, Idemyor was the MacArthur Foundation Visiting Senior Fellow at the University of Port Harcourt. In 2011, he was selected by the Nigeria National Universities’ Commission to be a LEADS (Linkage with Expert and Academics in Diaspora Scheme) Scholar and Visiting Professor at the University of Port Harcourt.
He is currently Professor of Clinical Pharmacy and Management at the University of Port Harcourt, a position he has held since 2011.
Dr. Idemyor has more than 40 articles published in peer-reviewed international journals in the areas of clinical pharmacology and infectious diseases. He is co-author of Drug Discovery and Development, 3rd Edition and authored two chapters in O’Donnell’s Drug Injury, 4th Edition: “HIV Pharmacotherapy and Its Complications” and “Using Precision Medicine to Decrease Adverse Drug Reactions.” During the last 10 years he has provided ongoing consultation for the work and development that resulted in the issuance of US patent 11,253,512, Opioid Taper Regimen. He is currently involved in developing instructional modules for the impact of climate change on human health.
Vincent is recipient of many awards for his work including: the 2001 Research and Publications Achievement award; 2002 Benjamin Banneker award for Science and Technology; 2003 Illinois Department of Public Health “Red Ribbon Award”; the 2004 City of Chicago Commission on Human Relations Outstanding Achievement Award; and the 2007 Medical Award of the Year from the National Technical Association. Citations of his scientific publications were ranked globally in the top one percentile (1%) among the 239,701 scientific authors in the AIDS and HIV research literature database (2006).
In 1991, Dr. Idemyor joined the teaching faculty at the University of Illinois College of Medicine, at Chicago, and was Mercy Hospital Medical Center, Head, Section of Clinical Pharmacology 1991-1999. While at Mercy Hospital, he did some of the early clinical research work in the area of antibiotic resistance to bacterial infections in hospitals. Idemyor was the Director, Department of Pharmaceutical Services, at Advocate Bethany Hospital in Chicago from 2000 to 2006. In 2006, he led the United Nations accountability project in Nigeria, reviewing how the Global Fund for HIV, TB and malaria funds had been used at numerous agencies throughout the country.
In 2009, Idemyor was the MacArthur Foundation Visiting Senior Fellow at the University of Port Harcourt. In 2011, he was selected by the Nigeria National Universities’ Commission to be a LEADS (Linkage with Expert and Academics in Diaspora Scheme) Scholar and Visiting Professor at the University of Port Harcourt.
He is currently Professor of Clinical Pharmacy and Management at the University of Port Harcourt, a position he has held since 2011.
Dr. Idemyor has more than 40 articles published in peer-reviewed international journals in the areas of clinical pharmacology and infectious diseases. He is co-author of Drug Discovery and Development, 3rd Edition and authored two chapters in O’Donnell’s Drug Injury, 4th Edition: “HIV Pharmacotherapy and Its Complications” and “Using Precision Medicine to Decrease Adverse Drug Reactions.” During the last 10 years he has provided ongoing consultation for the work and development that resulted in the issuance of US patent 11,253,512, Opioid Taper Regimen. He is currently involved in developing instructional modules for the impact of climate change on human health.
Vincent is recipient of many awards for his work including: the 2001 Research and Publications Achievement award; 2002 Benjamin Banneker award for Science and Technology; 2003 Illinois Department of Public Health “Red Ribbon Award”; the 2004 City of Chicago Commission on Human Relations Outstanding Achievement Award; and the 2007 Medical Award of the Year from the National Technical Association. Citations of his scientific publications were ranked globally in the top one percentile (1%) among the 239,701 scientific authors in the AIDS and HIV research literature database (2006).